HCPCS Level II code J9276 describes a billed administration unit for injection of zanidatamab-hrii, 2 mg, representing the drug product itself for use in oncology infusion settings; the service type is drug administration and the typical site of service is an oncology infusion center or hospital outpatient infusion clinic where parenteral biologic oncology therapies are administered.

For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Antibody-Drug Conjugates, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only).